CVE-2019-17361

Description

In SaltStack Salt through 2019.2.0, the salt-api NET API with the ssh client enabled is vulnerable to command injection. This allows an unauthenticated attacker with network access to the API endpoint to execute arbitrary code on the salt-api host.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 2.0 •
EPSS 13.56% Top 10%
Vendor Advisory opensuse.org Vendor Advisory debian.org Vendor Advisory ubuntu.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://github.com/saltstack/salt/commits/master third party advisory patch
https://docs.saltstack.com/en/latest/topics/releases/2019.2.3.html#security-fix third party advisory release notes
http://lists.opensuse.org/opensuse-security-announce/2020-03/msg00026.html mailing list third party advisory vendor advisory
https://www.debian.org/security/2020/dsa-4676 third party advisory vendor advisory
https://usn.ubuntu.com/4459-1/ third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2019-17361?
CVE-2019-17361 has been scored as a critical severity vulnerability.
How to fix CVE-2019-17361?
To fix CVE-2019-17361, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-17361 being actively exploited in the wild?
It is possible that CVE-2019-17361 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~14% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.